Patrick J. Mahaffy, President and CEO at Clovis Oncology, Inc. (CLVS), bought 22,367 shares at $5.59 ($125K) on 2019-08-16, disclosed to the SEC on 2019-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.58 | 11,314 | $63K | 50.5% |
| 2 | $5.59 | 11,053 | $62K | 49.5% |
| Total | $5.58 avg | 22,367 | $125K | 100% |
| Filing → |
| CLVS | BUY | 2011-11-21 | $519K | — | Filing → |
| PHRM | BUY | 2006-03-03 | $100K | — | Filing → |